We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUHN
10201
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$83K ﹤0.01%
+28,533
New +$76.8K
IMH
10202
DELISTED
Impac Mortgage Holdings Inc.
IMH
$83K ﹤0.01%
27,174
+11,698
+76% +$22.8K
NAK
10203
PUT
Northern Dynasty Minerals
NAK
$913M
$81K ﹤0.01%
250,500
-317,000
-56% -$229K
BEST
10204
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$81K ﹤0.01%
+1,990
New +$106K
ADT icon
10205
CALL
ADT
ADT
$5.48B
$80K ﹤0.01%
10,200
-85,000
-89% -$668K
BKYI
10206
BIO-key International
BKYI
$3.7M
$80K ﹤0.01%
+126
New +$79.8K
CIK
10207
Credit Suisse Asset Management Income Fund
CIK
$134M
$80K ﹤0.01%
+25,497
New +$78.7K
RKTO
10208
Rocket One Inc
RKTO
$19.2M
$80K ﹤0.01%
+1,344
New +$59.3K
ITRG
10209
Integra Resources
ITRG
$562M
$80K ﹤0.01%
+8,156
New +$70.8K
UXIN
10210
Uxin Ltd
UXIN
$262M
$80K ﹤0.01%
+915
New +$102K
XTNT icon
10211
Xtant Medical Holdings
XTNT
$42.9M
$80K ﹤0.01%
+67,056
New +$86.3K
WHWK
10212
Whitehawk Therapeutics
WHWK
$256M
$80K ﹤0.01%
5,474
-131,262
-96% -$2.81M
USX
10213
CALL
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$80K ﹤0.01%
11,700
-7,300
-38% -$57K
ORN icon
10214
CALL
Orion Group Holdings
ORN
$404M
$79K ﹤0.01%
+15,900
New +$61.7K
RDI icon
10215
CALL
Reading International Class A
RDI
$36.6M
$79K ﹤0.01%
+15,800
New +$55.2K
TRVG
10216
CALL
trivago
TRVG
$358M
$79K ﹤0.01%
6,500
-1,060
-14% -$9.32K
ZSL icon
10217
CALL
ProShares UltraShort Silver
ZSL
$57.9M
$79K ﹤0.01%
72
-105
-59% -$142K
NPKI
10218
CALL
NPK International
NPKI
$1.21B
$79K ﹤0.01%
+41,200
New +$55.3K
ATCX
10219
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$79K ﹤0.01%
+11,169
New +$79.3K
NAVB
10220
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$79K ﹤0.01%
36,800
+17,100
+87% +$40.3K
AREC icon
10221
American Resources Corp
AREC
$312M
$78K ﹤0.01%
+39,911
New +$67.1K
CTOS icon
10222
CALL
Custom Truck One Source
CTOS
$2.38B
$78K ﹤0.01%
+10,600
New +$53.7K
HBM icon
10223
PUT
Hudbay
HBM
$11.8B
$78K ﹤0.01%
+11,100
New +$62.7K
TWM icon
10224
PUT
ProShares UltraShort Russell2000
TWM
$40.4M
$78K ﹤0.01%
780
-40
-5% -$5.29K
AQST icon
10225
CALL
Aquestive Therapeutics
AQST
$532M
$77K ﹤0.01%
14,300
-11,200
-44% -$67.1K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.